Health Care: Drugs

Genvec Inc (GNVC: NASDAQ)

$6.4 -0.02 | -0.31%
04/26/17 - 11:02 AM ET
Company Profile
Price and Volume
Recent Price 6.42
52 Week High 14.00
52 Week Low 2.70
Avg. Daily Vol. (Mil) 0.04
Beta (3 year) 2.35
Share Related Items
Mkt Cap (Mil) 14.60
Shares Out (Mil) 2.27
Float (Mil) 2.20
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.90
Current Ratio 4.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 28.57
Price/Book 3.10
Price/Cash Flow -2.60
Per Share Data
Earnings -2.78
Sales 0.22
Book Value 2.07
Cash Flow -2.51
Business Summary
Genvec Inc is a biopharmaceutical company. The Company is engaged in leveraging its proprietary AdenoVerse gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines.
General Information
910 Clopper Road
Suite 220N
Gaithersburg, MD 20878
Industry : Drugs
Sector: Health Care
Employees: 15
CEO: Douglas J. Swirsky
Short Interest
Current Month (Mil) 0.25
Previous Month (Mil) 0.27
Short Interest Ratio (Days) 6.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -75.10
Return on Investments -123.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with GNVC

Latest GNVC Headlines from TheStreet

More Financial News for GNVC

Press Releases for GNVC

See All Press Releases

Partner Headlines for GNVC

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter